Ally Olotu

Further analysis of correlates of protection from a phase 2a trial of the falciparum malaria vaccines RTS,S/AS01B and RTS,S/AS02A in malaria-naive adults.Olotu AI, Fegan G, Bejon P
J Infect Dis, (2010). 201:970-1

Response to "Poor control vaccines in two randomised trials of malaria vaccine?".Bejon P, Abdulla S, Lusingu J, Olotu A, Leach A, Lievens M, Tanner M, von Seidlein L
Vaccine, (2009). 27:4745-6

Characteristics and outcome of cardiopulmonary resuscitation in hospitalised African children.Olotu A, Ndiritu M, Ismael M, Mohammed S, Mithwani S, Maitland K, Newton CR
Resuscitation, (2009). 80:69-72

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age.Bejon P, Lusingu J, Olotu A, Leach A, Lievens M, Vekemans J, Mshamu S, Lang T, Gould J, Dubois MC, Demoitie MA, Stallaert JF, Vansadia P, Carter T, Njuguna P, Awuondo KO, Malabeja A, Abdul O, Gesase S, Mturi N, Drakeley CJ, Savarese B, Villafana T, Ballou WR, Cohen J, Riley EM, Lemnge MM, Marsh K, von Seidlein L
N Engl J Med, (2008). 359:2521-32

Haemolytic uraemic syndrome in children admitted to a rural district hospital in Kenya.Olotu AI, Mithwani S, Newton CR
Trop Doct, (2008). 38:165-7